Retrophin, Inc. (NASDAQ:RTRX) A Buying Opportunity
Retrophin, Inc. (NASDAQ:RTRX) A Buying Opportunity Tech giants see healthcare and pharma as the next big thing RetrophinTicker: NASDAQ:RTRXPrice: $15.32 The global biopharmaceuticals market is found witnessing a CAGR of 7.14%. The market is largely driven by the growing geriatric population, increasing burden of chronic diseases, and rising inclination toward targeted therapy. Also, the huge […]